Cetrelimab (PDCD1/PD1/CD279) - Research Grade Biosimilar
Product Specifications
Background
Cetrelimab (JNJ-63723283) is a Programmed Cell Death Receptor-1 (PD-1) Inhibitor.
Immunogen
Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer, Immunology
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
JNJ-63723283
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6478402 1.0 µg DNA
RGD1562658 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details 12180066 1.0 µg DNA
APOC4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
BNCB2699-100 1x 100 µL
Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 